Myohub M Tablet is a thoughtfully formulated combination designed to support metabolic health, especially in women dealing with polycystic ovary syndrome (PCOS) or insulin resistance-related conditions. It contains Metformin, a well-established antidiabetic agent that enhances insulin sensitivity and reduces hepatic glucose production. Myo-Inositol, a naturally occurring vitamin-like substance, plays a crucial role in insulin signaling and ovarian function regulation.
Together, this combination works synergistically to restore hormonal balance, improve ovulatory function, and enhance fertility outcomes in women with PCOS. It also supports better glycemic control, thereby reducing the risk of type 2 diabetes development. Metformin works by improving the body’s response to insulin, while Myo-Inositol supports cellular signaling, oocyte quality, and reproductive hormone balance. This dual approach makes Myohub M a valuable therapeutic option not only for reproductive health but also for metabolic wellness.
Myohub M Tablet is often recommended as a part of long-term management for PCOS-related symptoms such as irregular menstrual cycles, acne, hirsutism (excess hair growth), and weight gain. It also aids in reducing androgen levels, promoting regular ovulation and improving fertility potential.
Additionally, this formulation may be beneficial for individuals experiencing insulin resistance or prediabetes, offering a preventive strategy against the progression of metabolic disorders. It is a well-tolerated regimen that is increasingly becoming a preferred choice among gynecologists and endocrinologists.